Yinghui Yu

Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province

Hangzhou, 310009

China

  • Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province

SCHOLARLY PAPERS

1

DOWNLOADS

78

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Ensartinib Confers Potent in Vitro and in Vivo Antitumor Activity in Non-Small Cell Lung Cancer Harboring MET Exon 14-Skipping Mutations

Number of pages: 29 Posted: 05 Apr 2022
Yang Xia, Rui Jin, Fen Lan, Ting Zhang, Jing Zhao, Yinghui Yu, Zhihua Chen, Songmin Ying, Huahao Shen and Wen Li
Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Department of Radiation Oncology, Zhejiang University - Department of Radiation Oncology, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province and Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province
Downloads 78 (677,086)

Abstract:

Loading...

Ensartinib, MET exon 14 skipping. mutation, non-small cell lung cancer, antitumor efficacy.